Recently, a pharmacological blocker of AQP4, which is also an inhibitor of Na+-K+-2Cl- cotransporter, has been shown to reduce edema post-ischemia at the 24-hour time point; however, the beneficial effect is reversed at 48 hours (20). The gene discussed is AQP4; the disease is ischemia.